Access Bio (Korea) Price Prediction
| 950130 Stock | KRW 5,540 170.00 2.98% |
Oversold Vs Overbought
40
Oversold | Overbought |
Using Access Bio hype-based prediction, you can estimate the value of Access Bio from the perspective of Access Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Access Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Access because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Access Bio after-hype prediction price | KRW 5540.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Access |
Access Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Access Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Access Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Access Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Access Bio Estimiated After-Hype Price Volatility
In the context of predicting Access Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Access Bio's historical news coverage. Access Bio's after-hype downside and upside margins for the prediction period are 5,538 and 5,542, respectively. We have considered Access Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Access Bio is very steady at this time. Analysis and calculation of next after-hype price of Access Bio is based on 3 months time horizon.
Access Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Access Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Access Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Access Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 2.24 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5,540 | 5,540 | 0.00 |
|
Access Bio Hype Timeline
Access Bio is presently traded for 5,540on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Access is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at -0.31%. %. The volatility of related hype on Access Bio is about 0.0%, with the expected price after the next announcement by competition of 5,540. About 25.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 149.71. Access Bio had not issued any dividends in recent years. Assuming the 90 days trading horizon the next estimated press release will be in 5 to 10 days. Check out Access Bio Basic Forecasting Models to cross-verify your projections.Access Bio Related Hype Analysis
Having access to credible news sources related to Access Bio's direct competition is more important than ever and may enhance your ability to predict Access Bio's future price movements. Getting to know how Access Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Access Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 205470 | Humasis Co | 0.00 | 0 per month | 0.00 | (0.06) | 8.88 | (6.06) | 40.38 | |
| 228670 | Ray Co | 0.00 | 0 per month | 0.00 | (0.24) | 3.85 | (5.12) | 17.68 | |
| 263690 | DRGEM | 0.00 | 0 per month | 0.00 | (0.26) | 3.21 | (3.16) | 10.51 | |
| 246710 | TR Biofab Co | 0.00 | 0 per month | 0.00 | (0.07) | 4.27 | (4.24) | 16.21 | |
| 131030 | DHP Korea Co | 0.00 | 0 per month | 0.00 | (0.16) | 4.14 | (4.59) | 15.70 | |
| 253840 | Sugentech | 0.00 | 0 per month | 0.00 | (0.19) | 6.30 | (6.81) | 17.18 | |
| 226400 | Osteonic Co | 0.00 | 0 per month | 0.00 | (0.07) | 6.44 | (5.49) | 19.68 |
Access Bio Additional Predictive Modules
Most predictive techniques to examine Access price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Access using various technical indicators. When you analyze Access charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Access Bio Predictive Indicators
The successful prediction of Access Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Access Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Access Bio based on analysis of Access Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Access Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Access Bio's related companies.
Story Coverage note for Access Bio
The number of cover stories for Access Bio depends on current market conditions and Access Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Access Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Access Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Access Bio Short Properties
Access Bio's future price predictability will typically decrease when Access Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Access Bio often depends not only on the future outlook of the potential Access Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Access Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 35.6 M | |
| Cash And Short Term Investments | 169 M | |
| Shares Float | 25.6 M |
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |